← Back to headlines
Elite Pharmaceuticals Director Purchases Company Stock
Barry Dash, a director at Elite Pharmaceuticals, purchased $8,610 worth of common stock, signaling insider confidence in the company.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
